Posted in the category:

HPAN

Defining SOD1 ALS natural history to guide therapeutic clinical trial design

Posted on July 11, 2016

Bali T, Self W, Liu J, et al: 2016 Neurodegeneration, doi:10.1136/jnnp-2016-313521 Read More

Posted in: HPAN, Neurodegeneration, NeuroRestorative Therapy, Publications Faculty: ,

Increased 4R-Tau Induces Pathological Changes in a Human-Tau Mouse Model

Posted on July 11, 2016

Schoch KM, DeVos SL, Miller RL, et al: 2015 Neuron, 90(5), pp. 941-947 Read More

Posted in: HPAN, Neurodegeneration, NeuroRestorative Therapy, Publications Faculty: ,

Perturbation of the O-U-O Angle in Uranyl by Coordination to a 12-Membered Macrocycle

Posted on July 11, 2016

Pedrick EA, Schultz JW, Wu G, et al: 2016, Inorganic Chemistry, 55(11), pp 5693-5701 Read More

Posted in: HPAN, Neurodegeneration, Publications Faculty:

Aromatic cyanoalkylation through double c-h activation mediated by Ni(III)

Posted on July 11, 2016

Zhou W, Zheng S, Schultz JW, et al: 2016 Journal of the American Chemical Society, 138(18), pp 5777-5780 Read More

Posted in: HPAN, Neurodegeneration, Publications Faculty:

Oxidatively-induced aromatic cyanation mediated by Ni(III)

Posted on July 11, 2016

Zhou W, Rath NP, Mirica LM: 2016 Dalton Transactions, 45(21), pp 8693-8695 Read More

Posted in: HPAN, Neurodegeneration, Publications Faculty: